Ranibizumab Intravitreal Injections Versus Sham Control in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT02390245` - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study	N/A
Active, not recruiting	`NCT04120311` - Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Not yet recruiting	`NCT04601688` - Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.	N/A
Completed	`NCT01968239` - Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT	Phase 2
Completed	`NCT00612261` - Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion	N/A
Not yet recruiting	`NCT03637283` - Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage	N/A
Completed	`NCT01471691` - Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab	Phase 1/Phase 2
Completed	`NCT01247220` - REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study	Phase 2
Terminated	`NCT00642226` - Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)	Phase 3
Terminated	`NCT05127525` - EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)	Phase 3
Completed	`NCT01599650` - Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion	Phase 3
Active, not recruiting	`NCT04120636` - Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Recruiting	`NCT01975103` - Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases	Phase 2
Recruiting	`NCT01348633` - Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye	N/A
Completed	`NCT04740905` - A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion	Phase 3
Recruiting	`NCT02527733` - Retinal Sensitivity in BRVO After Anti-VEGF Therapy	Phase 4
Completed	`NCT01396057` - Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)	Phase 3
Terminated	`NCT03802630` - Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion	Phase 3
Completed	`NCT02478515` - Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion	Phase 4
Terminated	`NCT01795209` - Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision	Phase 4

NCT number	NCT01976338
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	November 2013
Completion date	March 2016

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) — Blossom

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms